Approximately 13% of patients with Wiskott-Aldrich syndrome (WAS), a primary immune deficiency, develop malignant tumors, the predominant form being non-Hodgkin's lymphoma. Previously, only 4 cases of Hodgkin's lymphoma have been reported in WAS patients. Herein, we review the literature of WAS-related lymphomas and report 2 brothers with WAS who both developed lymphomas; one developed Epstein-Barr virus (EBV)-driven diffuse large B-cell lymphoma, and one developed EBV-negative classical Hodgkin's lymphoma. In contrast to many of the previously reported lymphomas in WAS patients, these lymphomas were extensively evaluated by means of molecular, flow cytometric, and immunohistochemical methods. Both brothers died shortly after diagnosis, despite aggressive therapy. The occurrence of 2 distinct forms of lymphomas in these brothers underscores the interplay between genetic susceptibility and environmental exposure in lymphoma pathogenesis.
OchsHDThrasherAJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol2006;117:725–738.
3.
MuellerBUPizzoPA. Cancer in children with primary or secondary immunodeficiencies. J Pediatr1995;126:1–10.
4.
SullivanKEMullenCABlaeseRMWinkelsteinJA. A multi-institutional survey of the Wiskott-Aldrich syndrome. J Pediatr1994;125:876–885.
5.
FillipovichAHMathurAKamatDShapiroRS. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res1992;52(suppl):5465s–5467s.
6.
CotelingamJDWitebskyFGHsuSMBlaeseRMJaffeES. Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Invest1985;3:515–522.
7.
NakanishiMKikutaHTomizawaK. Distinct clonotypic Epstein-Barr virus-induced fatal lymphoproliferative disorder in a patient with Wiskott-Aldrich syndrome. Cancer1993;72:1376–1381.
8.
YoshidaKMinegishiYOkawaH. Epstein-Barr virus-associated malignant lymphoma with macroamylasemia and monoclonal gammopathy in a patient with Wiskott-Aldrich syndrome. Pediatr Hematol Oncol1997;14:85–89.
9.
KroftSHFinnWGSingletonTPRossCWSheldonSSchnitzerB. Follicular large cell lymphoma with immunoblastic features in a child with Wiskott-Aldrich syndrome: an unusual immunodeficiency-related neoplasm not associated with Epstein-Barr virus. Am J Clin Pathol1998;110:95–99.
10.
GilsonDTaylorRE. Long-term survival following non-Hodgkin's lymphoma arising in Wiskott-Aldrich Syndrome. Clin Oncol1999;11:283–285.
11.
KawakamiKYamaguchiMWatanabeYMurataT. Development of diffuse large cell lymphoma from follicular lymphoma with multiple immunoglobulin heavy chain gene rearrangement occurring in a patient with Wiskott-Aldrich syndrome. Int J Hematol2002;76:196–198.
12.
PalenzuelaGBernardFGardinerQMondainM. Malignant B cell non-Hodgkin's lymphoma of the larynx in children with Wiskott-Aldrich syndrome. Int J Pediatr Otorhinolaryngol2003;67:989–993.
ChinenJAnmuthDFranklinARShearerWT. Long-term follow-up of patients with primary immunodeficiencies. J Allergy Clin Immunol2007;120:795–797.
15.
PerimanPCallihanTRLessinLKingGWBlasseM. Hodgkin's disease occurring in a patient with the Wiskott-Aldrich syndrome. Cancer1980;45:372–376.
16.
SasaharaYFulieHKumakiSOhashiYMinegishiMTsuchiyaS. Epstein-Barr virus-associated Hodgkin's disease in a pt with Wiskott-Aldrich Syndrome. Acta Paediatr2001;90:1348–1351.
17.
IlowiteNTFlignerCLOchsHD. Pulmonary angiitis with atypical lymphoreticular infiltrates in Wiskott-Aldrich syndrome: possible relationship of lymphomatoid granulomatosis and EBV infection. Clin Immunol Immunopathol1986;41:479–484.
18.
SebireNJHaseldenSMaloneMDaviesEGRamsayAD. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol2003;56:555–557.
19.
MeropolNJHicksDBrooksJJ. Coincident Kaposi sarcoma and T-cell lymphoma in a patient with the Wiskott-Aldrich syndrome. Am J Hematol1992;40:126–134.
20.
WatsonRDGershwinMESmithwickECastlesJJRuebnerB. Cutaneous T cell lymphoma and leukocytoclastic vasculitis in a long-term survivor of Wiskott-Aldrich syndrome. Ann Allergy1985;55:654–657, 703–705.
21.
NakhlehREManivelJCCopenhaverCMSungJHStricklerJG. In situ hybridization for the detection of Epstein-Barr virus in central nervous system lymphomas. Cancer1991;67:444–448.
22.
GulleyMLChenC-LRaab-TraubN. Epstein-Barr virus-related lymphomagenesis in a child with Wiskott-Aldrich syndrome. Hematol Oncol1993;11:139–145.
23.
SandrockDLastoriaSMerinoMJNeumannRD. Positive gallium-67 citrate scintigraphy in Wiskott-Aldrich syndrome with malignant lymphoma. Eur J Nucl Med1991;18:928–930.
24.
HutterJJJrJonesJF. Results of a thymic epithelial transplant in a child with Wiskott-Aldrich syndrome and central nervous system lymphoma. Clin Immunol Immunopathol1981;18:121–125.
25.
ModelLM. Primary reticulum cell sarcoma of the brain in Wiskott-Aldrich syndrome. Report of a case. Arch Neurol1977;34:633–635.
26.
HeidelbergerKPLeGolvanDP. Wiskott-Aldrich syndrome and cerebral neoplasia: report of a case with localized reticulum cell sarcoma. Cancer1974;33:280–284.
27.
BrandMMMarinkovichVA. Primary malignant reticulosis of the brain in Wiskott-Aldrich syndrome. Report of a case. Arch Dis Child1969;44:536–542.
28.
LemahieuVGastierJMFranckeU. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes. Hum Mutat1999;14:54–66.
29.
HsiED. Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment. Leuk Lymphoma2008;49:1668–1680.
